Fetal Focus™: The next-generation sgNIPT enables actionable interventions

Fetal Focus™:

The next-generation single-gene NIPT enables actionable interventions

Available session:

Date: Thursday, February 19, 2026

Time: 2:00 PM PT | 5:00 PM ET

Registrants will receive a recording of the webinar approximately one week after the event.

Fetal Focus™, the next-generation single-gene NIPT, is now available for up to 21 recessive and X-linked conditions. By directly screening the fetus using cfDNA from the pregnant Horizon™ carrier’s sample, Fetal Focus™ provides fetal risk insights without requiring a partner’s sample.

Hear from Dr. Lee Shulman and Dr. Jeffrey Meltzer as they discuss the clinical utility of Fetal Focus™ in enabling earlier diagnosis and treatment of inherited single-gene conditions.

Learn more about:

How Fetal Focus™ can overcome challenges in the current carrier screening paradigm and help standardize prenatal genetic testing
Fetal Focus's ultra-sensitive LinkedSNP™ technology and outstanding performance data in the EXPAND clinical study
The clinical actionability of the conditions screened by Fetal Focus™, including the latest FDA-approved and emerging interventional treatments

Natera Honey Pot

Register Now:

First Name*

Last Name*

Email Address*

Job Title*

Phone*

Company Name*

Postal Code*

Country*

I am a*

Available Webinar Sessions and Dates*

Do you have any questions for the presenters that you would like to submit before the webinar?

Please fill in the field above only if you have specific questions. Otherwise, leave it blank.

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time.

Hear from our speakers:

Lee Shulman, MD, FACMG, FACOG

OBGYN, Professor of OBGYN, and Director of Clinical Genetics

Department of OBGYN of the Feinberg School of Medicine

Northwestern University

Jeffrey Meltzer, MD, MBA, FACOG

OBGYN and Principal Medical Director

Women’s Health

Natera

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the tests. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.

13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy